LSV Asset Management Lowers Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

LSV Asset Management lowered its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 23.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 451,000 shares of the company’s stock after selling 139,700 shares during the quarter. LSV Asset Management owned about 0.91% of Prestige Consumer Healthcare worth $32,725,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. GAMMA Investing LLC bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $25,000. Pacer Advisors Inc. grew its stake in shares of Prestige Consumer Healthcare by 85.7% in the 4th quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after buying an additional 204 shares in the last quarter. Principal Securities Inc. bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth about $29,000. ORG Partners LLC bought a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth about $36,000. Finally, Parallel Advisors LLC lifted its holdings in shares of Prestige Consumer Healthcare by 42.5% in the 4th quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after acquiring an additional 213 shares during the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.2 %

PBH traded up $0.12 on Friday, reaching $70.33. 206,179 shares of the company traded hands, compared to its average volume of 247,724. Prestige Consumer Healthcare Inc. has a one year low of $56.34 and a one year high of $75.31. The firm has a fifty day simple moving average of $66.74 and a two-hundred day simple moving average of $67.15. The company has a market cap of $3.49 billion, a P/E ratio of 16.87, a price-to-earnings-growth ratio of 1.93 and a beta of 0.49. The company has a quick ratio of 2.02, a current ratio of 3.20 and a debt-to-equity ratio of 0.68.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). The business had revenue of $277.00 million for the quarter, compared to analysts’ expectations of $287.42 million. Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period last year, the business posted $1.07 EPS. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. StockNews.com lowered shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 21st. Canaccord Genuity Group restated a “buy” rating and issued a $80.00 target price on shares of Prestige Consumer Healthcare in a report on Tuesday, May 21st. Finally, DA Davidson upgraded shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and raised their target price for the stock from $65.00 to $93.00 in a report on Friday, June 21st. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $98.25.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.